We're sorry but the Program doesn't work properly without JavaScript enabled. Please enable it to continue.
Horizontal
Vertical
List
Program
Chairs & Speakers
Favourites
Download Program
Help
Event Times (GMT+1)
Local Times (GMT+2)
Login
Session Groups
Session Types
Networking
Data Blitz Session
Spotlight Session
Symposium
Meet the Experts / Campfire Session
Plenary
Break
Session
Industry
Posters
Featured Communication
Rooms
Back
Ülkü Günar
University of Edinburgh, Edinburgh, United Kingdom
In presentations
Sunday, June 28, 01:20 PM – 01:20 PM
Chronic oral administration of olanzapine, a D2 and 5-HT2A/C receptor antagonist, modifies the synaptome architecture in a mouse model of schizophrenia and bipolar disorder
Speaker: Ülkü Günar (University of Edinburgh, Institute for Neuroscience and Cardiovascular Research, Edinburgh, United Kingdom)
